Amplify Development LLC

Last year, a new crop of biotechnology exchanged-traded funds brought refined, laser-like focus to the fast-growing market segment. Biotech ETFs making their debuts in late 2014 included funds devoted exclusively to companies with products in specific stages of clinical trials or only to those...